Sign in

CIK 0001821586

  • Large accelerated filer

MoonLake Immunotherapeutics

Sign in to watch
Ticker
MLTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
Phone
+41 415108022
Business address
DORFSTRASSE 29, ZUG, Switzerland, 6300
Former names
Helix Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-06-05 Sturge Simon Director Grant or award · Option to Buy +6,682 6,682
2024-10-04 Sturge Simon Director Sale −171,000 $53.72 $9.2M 171,980
2024-06-06 Sturge Simon Director Grant or award · Option to Buy +7,688 7,688
2023-10-01 Sturge Simon Director Conversion +342,980 342,980
2023-10-01 Sturge Simon Director Returned to the company −342,980 0
2023-10-01 Sturge Simon Director Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG −10,196 0
2023-06-08 Sturge Simon Director Grant or award · Option to Buy +11,297 11,297
2022-04-06 Sturge Simon Director Grant or award · Option to Buy +45,000 45,000

Page 1 of 1 · 8 trades